248 related articles for article (PubMed ID: 32046777)
21. Growth Differentiation Factor 15 Promotes Progression of Esophageal Squamous Cell Carcinoma via TGF-β Type II Receptor Activation.
Okamoto M; Koma YI; Kodama T; Nishio M; Shigeoka M; Yokozaki H
Pathobiology; 2020; 87(2):100-113. PubMed ID: 31896114
[TBL] [Abstract][Full Text] [Related]
22. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
23. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
[TBL] [Abstract][Full Text] [Related]
24. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
25. ATAD2 interacts with C/EBPβ to promote esophageal squamous cell carcinoma metastasis via TGF-β1/Smad3 signaling.
Cao LJ; Zhang YJ; Dong SQ; Li XZ; Tong XT; Chen D; Wu ZY; Zheng XH; Xue WQ; Jia WH; Zhang JB
J Exp Clin Cancer Res; 2021 Mar; 40(1):109. PubMed ID: 33757572
[TBL] [Abstract][Full Text] [Related]
26. The promoter hypermethylation of SULT2B1 accelerates esophagus tumorigenesis via downregulated PER1.
Li Z; Li MY; Wang LL; Li L; Chen QY; Zhu YH; Li Y; Qin YR; Guan XY
Thorac Cancer; 2021 Dec; 12(24):3370-3379. PubMed ID: 34730281
[TBL] [Abstract][Full Text] [Related]
27. Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma.
Tang H; Jiang L; Zhu C; Liu R; Wu Y; Yan Q; Liu M; Jia Y; Chen J; Qin Y; Lee VH; Luo S; Wang Q; Guan XY
Oncogene; 2019 Apr; 38(17):3119-3133. PubMed ID: 30622339
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
29. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
Ma K; Cao B; Guo M
Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.
Guo M; Ren J; Brock MV; Herman JG; Carraway HE
Epigenetics; 2008 Nov; 3(6):336-41. PubMed ID: 19098448
[TBL] [Abstract][Full Text] [Related]
31. Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
Zhang W; Yan W; Qian N; Han Q; Zhang W; Dai G
Chin Med J (Engl); 2022 Feb; 135(5):606-618. PubMed ID: 35191417
[TBL] [Abstract][Full Text] [Related]
32. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma.
Dong Z; Yang L; Lu J; Guo Y; Shen S; Liang J; Guo W
Clin Exp Metastasis; 2022 Aug; 39(4):661-677. PubMed ID: 35616822
[TBL] [Abstract][Full Text] [Related]
35. CDK11
Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
[TBL] [Abstract][Full Text] [Related]
36. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
37. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
Chen C; Ma Z; Zhang H; Liu X; Yu Z
Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.
Meng Y; Wang QG; Wang JX; Zhu ST; Jiao Y; Li P; Zhang ST
Dig Dis Sci; 2011 Nov; 56(11):3195-203. PubMed ID: 21567192
[TBL] [Abstract][Full Text] [Related]
39. 19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer.
Sun R; Xiang T; Tang J; Peng W; Luo J; Li L; Qiu Z; Tan Y; Ye L; Zhang M; Ren G; Tao Q
Theranostics; 2020; 10(5):2243-2259. PubMed ID: 32089740
[TBL] [Abstract][Full Text] [Related]
40. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
